1-4 of 4
Mike Cusnir
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R289, a Dual Irak 1/4 Inhibitor, in Patients with Relapsed/Refractory (R/R) Lower-Risk Myelodysplastic Syndrome (LR-MDS): Initial Results from a Phase 1b Study

Guillermo Garcia-Manero, Yazan F Madanat, Mikkael A. Sekeres, Hetty E. Carraway, Mike Cusnir, James McCloskey, Kiran Naqvi, Gary J. Schiller, Lucy Yan, Toufigh Gordi, Lisa Rojkjaer, Lewis R. Silverman
Journal: Blood
Blood (2024) 144 (Supplement 1): 4595.
https://doi.org/10.1182/blood-2024-206096
Published: 2024
Journal Articles

Examining Racial Disparities in Multiple Myeloma Research and Treatment

Ryan Petit, Mike Cusnir
Journal: Blood
Blood (2023) 142 (Supplement 1): 7408.
https://doi.org/10.1182/blood-2023-190669
Published: 2023
Journal Articles

Outcomes of R-Mini-CHOP Therapy for Elderly Patients with Diffused Large B Cell Lymphoma (DLBCL) and High-Grade Follicular Lymphoma (FL)

Veronica A Guerra, Marisol Ocampo, Mike Cusnir
Journal: Blood
Blood (2021) 138 (Supplement 1): 4581.
https://doi.org/10.1182/blood-2021-153702
Published: 2021
Journal Articles

Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy

Veronica A Guerra, Marisol Ocampo, Mike Cusnir
Journal: Blood
Blood (2021) 138 (Supplement 1): 3554.
https://doi.org/10.1182/blood-2021-154090
Published: 2021